Literature DB >> 7758513

Pelvic ultrasonography: early differentiation between isolated premature thelarche and central precocious puberty.

H P Haber1, H A Wollmann, M B Ranke.   

Abstract

We examined 55 girls with isolated premature thelarche between the ages of 0.3 and 7.4 years (group A), 20 children with central precocious puberty between 2.1 and 7.7 years of age and 101 age-matched controls. The children with precocious puberty were divided according to distribution of pubic hair into group B (Tanner stages PH1, B2-3; n = 11), representing an early stage of the disorder, and group C (stages PH2-3, B3-4; n = 9), representing an advanced stage. Uterine and ovarian volumes were measured sonographically, peak serum levels of luteinizing hormone and follicle-stimulating hormone were determined after intravenous administration of luteinizing hormone-releasing hormone. The mean uterine and ovarian volumes were significantly greater in children with precocious puberty than in controls (group B: uterine volume: 3.8 +/- 2.0 ml vs 0.9 +/- 0.3 ml for controls, P < 0.001; ovarian volume: 2.2 +/- 1.3 ml vs 0.6 +/- 0.2 ml for controls, P < 0.01; group C: uterine volume: 8.0 +/- 4.4 ml vs 1.0 +/- 0.3 ml for controls, P < 0.01; ovarian volume; 2.6 +/- 1.3 ml vs 0.4 +/- 0.1 ml, P < 0.01). No significant differences were found between children with premature thelarche and the control group. As a diagnostic method for the early detection of central precocious puberty, ultrasound measurement of uterine volume had a sensitivity and specificity of 100% (cut-off value, 1.8 ml), while ultrasound determination of ovarian volume had a sensitivity of 82% and a specificity of 95% (cut-off value, 1.2 ml).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7758513     DOI: 10.1007/BF01954267

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  [Diagnostic differentiation between precocious puberty and premature thelarche using ultrasonography and the stimulated LH/FSH quotient].

Authors:  V Pelzer; M Von Ditfurth; U Wendel
Journal:  Geburtshilfe Frauenheilkd       Date:  1990-12       Impact factor: 2.915

2.  Studies of gonadotrophin pulsatility and pelvic ultrasound examinations distinguish between isolated premature thelarche and central precocious puberty.

Authors:  R Stanhope; N A Abdulwahid; J Adams; C G Brook
Journal:  Eur J Pediatr       Date:  1986-08       Impact factor: 3.183

3.  Plasma concentration of oestradiol-17beta in premature thelarche and in different types of sexual precocity.

Authors:  M E Escobar; M A Rivarola; C Bergadá
Journal:  Acta Endocrinol (Copenh)       Date:  1976-02

4.  Responsivity of pituitary gonadotropes to luteinizing hormone-releasing factor in idiopathic precocious puberty, precocious thelarche, precocious adrenarche, and in patients treated with medroxyprogesterone acetate.

Authors:  E O Reiter; S L Kaplan; F A Conte; M M Grumbach
Journal:  Pediatr Res       Date:  1975-02       Impact factor: 3.756

5.  Bioactive LH: a test to discriminate true precocious puberty from premature thelarche and adrenarche.

Authors:  A W Lucky; B H Rich; R L Rosenfield; V S Fang; N Roche-Bender
Journal:  J Pediatr       Date:  1980-08       Impact factor: 4.406

6.  Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone.

Authors:  O H Pescovitz; K D Hench; K M Barnes; D L Loriaux; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1988-09       Impact factor: 5.958

7.  Hormonal changes in puberty. IV. Plasma estradiol, LH, and FSH in prepubertal children, pubertal females, and in precocious puberty, premature thelarche, hypogonadism, and in a child with a feminizing ovarian tumor.

Authors:  M R Jenner; R P Kelch; S L Kaplan; M M Grümbach
Journal:  J Clin Endocrinol Metab       Date:  1972-03       Impact factor: 5.958

8.  Pelvic ultrasonography in girls with precocious puberty, congenital adrenal hyperplasia, obesity, or hirsutism.

Authors:  S Salardi; L F Orsini; E Cacciari; S Partesotti; L Brondelli; A Cicognani; E Frejaville; V Pluchinotta; S Tonioli; L Bovicelli
Journal:  J Pediatr       Date:  1988-06       Impact factor: 4.406

9.  [The significance and characteristics of the LHRH test in diagnosing precocious puberty development in girls: the stimulated LH/FSH quotient differentiates between central precocious puberty and premature thelarche].

Authors:  C J Partsch; R Hümmelink; F Lorenzen; W G Sippell
Journal:  Monatsschr Kinderheilkd       Date:  1989-05       Impact factor: 0.323

10.  Hypothalamic-pituitary-gonadotropic function in girls with premature thelarche.

Authors:  A M Pasquino; F Piccolo; A Scalamandre; M Malvaso; R Ortolani; B Boscherini
Journal:  Arch Dis Child       Date:  1980-12       Impact factor: 3.791

View more
  17 in total

1.  Central precocious puberty following the diagnosis and treatment of paediatric cancer and central nervous system tumours: presentation and long-term outcomes.

Authors:  Wassim Chemaitilly; Thomas E Merchant; Zhenghong Li; Nicole Barnes; Gregory T Armstrong; Kirsten K Ness; Ching-Hon Pui; Larry E Kun; Leslie L Robison; Melissa M Hudson; Charles A Sklar; Amar Gajjar
Journal:  Clin Endocrinol (Oxf)       Date:  2015-11-16       Impact factor: 3.478

Review 2.  Central precocious puberty: current treatment options.

Authors:  Franco Antoniazzi; Giorgio Zamboni
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

3.  An Evidence-Based Model of Multidisciplinary Care for Patients and Families Affected by Classical Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.

Authors:  Traci L Schaeffer; Jeanie B Tryggestad; Ashwini Mallappa; Adam E Hanna; Sowmya Krishnan; Steven D Chernausek; Laura J Chalmers; William G Reiner; Brad P Kropp; Amy B Wisniewski
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-18

4.  Plasma kisspeptin levels in girls with premature thelarche.

Authors:  Ayşehan Akinci; Dilek Cetin; Nevin Ilhan
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

5.  Serum kisspeptin levels in Korean girls with central precocious puberty.

Authors:  Young Jun Rhie; Kee Hyoung Lee; So Hee Eun; Byung Min Choi; Hyun Wook Chae; Ah Reum Kwon; Woo Jung Lee; Jung Hyun Kim; Ho-Seong Kim
Journal:  J Korean Med Sci       Date:  2011-06-20       Impact factor: 2.153

Review 6.  Endocrinopathies in survivors of childhood neoplasia.

Authors:  Nicole Barnes; Wassim Chemaitilly
Journal:  Front Pediatr       Date:  2014-09-23       Impact factor: 3.418

7.  Is premature thelarche in the first two years of life transient?

Authors:  Ahmet Uçar; Nurçin Saka; Firdevs Baş; Rüveyde Bundak; Hülya Günöz; Feyza Darendeliler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-09

8.  Clinical and laboratory characteristics of children referred for early puberty: preponderance in 7-8 years of age.

Authors:  Ayşe Kılıç; Mehmet Sait Durmuş; Emin Ünüvar; Ismail Yıldız; Banu Küçükemre Aydın; Ahmet Uçar; Rüveyde Bundak; Firdevs Baş; Feyza Darendeliler; Fatma Oğuz; Müjgan Sıdal; Ensar Yekeler
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-12

9.  Usefulness of pelvic ultrasonography for the diagnosis of central precocious puberty in girls.

Authors:  Jung Yu; Ha Young Shin; Sun Hee Lee; You Sung Kim; Jae Hyun Kim
Journal:  Korean J Pediatr       Date:  2015-08-21

10.  A Validated Normative Model for Human Uterine Volume from Birth to Age 40 Years.

Authors:  Thomas W Kelsey; Eleanor Ginbey; Moti M Chowdhury; Louise E Bath; Richard A Anderson; W Hamish B Wallace
Journal:  PLoS One       Date:  2016-06-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.